Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Chun-Feng Chang"'
Autor:
Chi-Hao Liu, Chun-Feng Chang, I-Chien Chen, Fan-Min Lin, Shiow-Jyu Tzou, Chung-Bao Hsieh, Ta-Wei Chu, Dee Pei
Publikováno v:
Diagnostics, Vol 14, Iss 10, p 979 (2024)
The identification of risk factors for future prediabetes in young men remains largely unexamined. This study enrolled 6247 young ethnic Chinese men with normal fasting plasma glucose at the baseline (FPGbase), and used machine learning (Mach-L) meth
Externí odkaz:
https://doaj.org/article/64691758e694458abbc84f674b9dc80f
Autor:
Yi-Qi Huang, Amina M Illias, Po-Jen Chen, Su-Ying Chien, Yueh-Hsiung Kuo, Chou-Yuan Ko, Chun-Feng Chang, Zhi-Hong Wen, Tsong-Long Hwang, Ping-Jyun Sung
Publikováno v:
Tetrahedron Letters. :154540
Autor:
Jiun-Tai Chen, Wen Ding Fu, Vamsi Krishna Karapala, Chun Feng Chang, Yi Jia Su, Sheng Jhih Lu, Hung Min Shih, Tsung Wei Chen, Ko Jui Ma, Chain-Shu Hsu, Ping Lien Lu, Tzu Yuan Lee
Publikováno v:
ACS Applied Energy Materials. 4:2847-2855
In this study, two dithieno[3,2-b]thiophenecyclopentacarbazole (DTTC)-based nonfullerene acceptors (NFAs) named DTTC-4F-C8 and DTTC-4Cl-C9 are designed, synthesized, and incorporated as the second ...
Autor:
Yi-Jia Su, Hebing Nie, Chun-Feng Chang, Sheng-Ci Huang, Yi-Hsuan Huang, Tsung-Wei Chen, Kuo-Kai Hsu, Tzu-Yuan Lee, Hung-Min Shih, Chung-Wen Ko, Jiun-Tai Chen, Chain-Shu Hsu
Publikováno v:
ACS applied materialsinterfaces. 13(49)
In this work, two asymmetric non-fullerene acceptors (NFAs), BTP-EHBO-4F and BTP-PHD-4F, are designed to be applied in green-solvent-processable organic photovoltaics (OPVs). BTP-EHBO-4F and BTP-PHD-4F show good solubilities in green solvent
Autor:
Chun-Feng Chang, Chiang-Ting Wang, Chien-Tai Mei, Ying-Jui Ni, Lung-Hsiang Cho, Chiao-Ching Li
Publikováno v:
Urological Science, Vol 26, Iss 2, p S38 (2015)
Externí odkaz:
https://doaj.org/article/a4e49d0cdffe414a949c15fb0b305a4a
Publikováno v:
Urological Science, Vol 26, Iss 4, Pp 304-305 (2015)
Externí odkaz:
https://doaj.org/article/7d76086c182b4eda887f18bb4b6f3df5
Autor:
Fu Ming Kuo, Chin Yu Lin, Chun Feng Chang, An Siou Li, Hsing Pang Hsieh, Teng Kuang Yeh, Jen Shin Song, Shu Yu Lin, Chun Hwa Chen, Mohane Selvaraj Coumar, Po Chu Kuo, Sing Yi Wang, Mu Chun Li, Wen-Hsing Lin, Chen Ming Yang, Pei Yi Chen, John T.A. Hsu
Publikováno v:
Bioorganic chemistry. 98
In an effort to develop new cancer therapeutics, we have reported clinical candidate BPR1K871 (1) as a potentanticancercompound in MOLM-13 and MV4-11 leukemia models, as well as in colorectal and pancreatic animal models. As BPR1K871 lacks oral bioav
Autor:
Chun-Ping Chang, Wen-Hsing Lin, Chun-Feng Chang, Jen-Shin Song, Pei-Yi Chen, Yi-Yu Ke, Wan-Ping Wang, Chuan Shih, Pei-Chen Wang, Po-Chu Kuo, Wen-Hsin Lin, Hsing Pang Hsieh, Chia-Hua Tsai, I-Chen Chiu, Ya-Hui Chi
Publikováno v:
European Journal of Medicinal Chemistry. 151:533-545
Twenty five novel chemical analogs of the previously reported Aurora kinase inhibitor BPR1K653 (1-(4-(2-((5-chloro-6-phenylfuro[2,3-d]pyrimidin-4-yl)amino)ethyl)phenyl)-3-(2-((dimethylamino)methyl)phenyl)urea) have been designed, synthesized, and eva
Autor:
John T.A. Hsu, Chun Hwa Chen, Hsing Pang Hsieh, Wen-Hsing Lin, Yih Shyan Lin, Biing-Jiun Uang, Chun Feng Chang, Wen Chieh Wang, Yi Yu Ke, Po Chu Kuo
Publikováno v:
European Journal of Medicinal Chemistry. 124:186-199
Aurora kinases have emerged as important anticancer targets so that there are several inhibitors have advanced into clinical study. Herein, we identified novel indazole derivatives as potent Aurora kinases inhibitors by utilizing in silico fragment-b
Publikováno v:
Proceedings of International Conference on Artificial Life and Robotics. 21:169-173